Preclinical Imaging Market

The global preclinical imaging market size was valued at USD 2.28 billion in 2024 and is expected to reach USD 3.72 billion by 2032, at a CAGR of 6.3% during the forecast period The market growth is largely fueled by the increasing adoption of advanced imaging technologies in drug discovery, biomedical research, and preclinical studies, driving enhanced visualization and accurate evaluation of disease models Furthermore, rising demand for high-resolution, non-invasive imaging solutions that accelerate translational research and reduce experimental costs is positioning preclinical imaging as a critical tool in pharmaceutical and academic research. These converging factors are accelerating the uptake of preclinical imaging solutions, thereby significantly boosting the industry's growth https://www.databridgemarketresearch.com/reports/global-preclinical-imaging-market